EUVIMEDEUVIMED entdecken
Crossref

Impact of Coronary Sinus Reducer on the Extent of Ischemia in Functional Stress Tests

Sheizaf Gefen iD, Gil Mashiah iD, Yoav Perez iD, Elina Stsiapanava, Miri Revivo, Haim Shmilovich, Shmuel Banai iD, Jeremy Ben-Shoshan, Maayan Konigstein iD

Circulation: Cardiovascular Interventions · 13.11.2026

DOI: 10.1161/circinterventions.126.017002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation: Cardiovascular Interventions, online erschienen am 13.11.2026. Verfasst von Sheizaf Gefen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Tel Aviv Sourasky University Medical Center (Ichilov), Israel (S.G., G.M., Y.P., E.S., M.R., H.S., S.B., J.B.-S., M.K.). Die Arbeit nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The coronary sinus reducer is an established therapy for patients with refractory angina due to obstructive coronary artery disease who are not candidates for further revascularization. Although symptomatic benefits are well documented, its effect on objective measures of ischemia remains unclear. This study aimed to evaluate the association between coronary sinus reducer implantation and inducible myocardial ischemia assessed by functional stress testing. METHODS: We retrospectively analyzed a prospectively maintained registry of consecutive patients undergoing coronary sinus reducer implantation between 2011 and 2024. Baseline assessment included Canadian Cardiovascular Society angina class, 6-minute walk test, stress echocardiography, and dipyridamole single-photon emission computed tomography imaging, repeated at 6 months. Coprimary outcomes were changes in stress wall motion score index and in the proportion of patients with moderate or severe ischemia on single-photon emission computed tomography. Clinical nonresponders were defined as no improvement in Canadian Cardiovascular Society class at 12 months. RESULTS: Among 153 treated patients, 118 had complete imaging data. Median stress wall motion score index improved from 1.38 to 1.23 ( P

Schlagwörter

Stichwörter der Autor:innen

coronary artery diseaseechocardiographyischemiaphysiciansrandomized controlled trial

Autor:innen und Institutionen

  • Division of Cardiology, Tel Aviv Sourasky University Medical Center (Ichilov), Israel (S.G., G.M., Y.P., E.S., M.R., H.S., S.B., J.B.-S., M.K.).
  • Gray Faculty of Medical and Health Sciences, Tel Aviv University, Israel (S.G., H.S., S.B., J.B.-S., M.K.).

ORCID-Profile: Sheizaf Gefen, Gil Mashiah, Yoav Perez, Shmuel Banai, Maayan Konigstein

Zitieren

APA

Gefen, S., Mashiah, G., Perez, Y., Stsiapanava, E., Revivo, M., Shmilovich, H., Banai, S., Ben-Shoshan, J., & Konigstein, M. (2026). Impact of Coronary Sinus Reducer on the Extent of Ischemia in Functional Stress Tests. Circulation: Cardiovascular Interventions. https://doi.org/10.1161/circinterventions.126.017002

Vancouver

Gefen S, Mashiah G, Perez Y, Stsiapanava E, Revivo M, Shmilovich H, et al. Impact of Coronary Sinus Reducer on the Extent of Ischemia in Functional Stress Tests. Circulation: Cardiovascular Interventions. 2026. doi:10.1161/circinterventions.126.017002

BibTeX
@article{Gefen2026,
  author = {Gefen, Sheizaf and Mashiah, Gil and Perez, Yoav and Stsiapanava, Elina and Revivo, Miri and Shmilovich, Haim and Banai, Shmuel and Ben-Shoshan, Jeremy and Konigstein, Maayan},
  title = {Impact of Coronary Sinus Reducer on the Extent of Ischemia in Functional Stress Tests},
  journal = {Circulation: Cardiovascular Interventions},
  year = {2026},
  doi = {10.1161/circinterventions.126.017002}
}
Kostenlos starten →